Rankings
▼
Calendar
FBLG FY 2020 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
FBLG
FibroBiologics, Inc. Common Stock
$17M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$1M
Net Income
-$1M
EPS (Diluted)
$-0.04
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$0
Cash & Equivalents
$0
← FY 2021
All Quarters
